中国卒中杂志2025，Vol.20Issue(5)：519-528,10.DOI:10.3969/j.issn.1673-5765.2025.05.001
从起步到辉煌——中国卒中临床研究发展20年
From Inception to Excellence:Two Decades of Stroke Clinical Research in China
摘要
Abstract
Stroke is one of the major diseases causing disability and death in Chinese residents,placing a significant burden on the healthcare system.Evidence-based medical research provides reliable data to guide stroke diagnosis and treatment,significantly reducing stroke-related disability and mortality rates.Over the past two decades,Chinese clinicist and researchers have played an increasingly prominent role in clinical research on stroke.Focusing on various aspects of stroke diagnosis and treatment,they have contributed valuable evidence-based medical evidence in major and hot fields such as reperfusion therapy for acute ischemic stroke,secondary prevention of stroke,brain cytoprotection,application of new devices and techniques,perioperative management of endovascular treatment,and quality control and management of stroke diagnosis and treatment.This article briefly reviews the development history of evidence-based medicine for stroke in China,summarizes the contributions and achievements of Chinese researchers in evidence-based practice for stroke diagnosis and treatment,and looks forward to the next phase of stroke research.关键词
循证医学/脑血管病/缺血性卒中/出血性卒中/再灌注/静脉溶栓/血管内治疗/二级预防Key words
Evidence-based medicine/Cerebrovascular disease/Ischemic stroke/Hemorrhagic stroke/Reperfusion/Intravenous thrombolysis/Endovascular treatment/Secondary prevention分类
医药卫生引用本文复制引用
熊云云,王拥军..从起步到辉煌——中国卒中临床研究发展20年[J].中国卒中杂志,2025,20(5):519-528,10.基金项目
四大慢病重大专项(2024ZD0527600,2024ZD0527605)国家自然科学基金面上项目(82171272)北京市杰出青年科学基金(JQ24058) （2024ZD0527600,2024ZD0527605）
